Molecular Partners AG (XSWX:MOLN)
CHF 3.305 -0.115 (-3.36%) Market Cap: 108.63 Mil Enterprise Value: -74.61 Mil PE Ratio: 0 PB Ratio: 0.64 GF Score: 53/100

Molecular Partners AG at JPMorgan Healthcare Conference Transcript

Jan 10, 2024 / 06:30PM GMT
Release Date Price: CHF4.02 (+4.15%)
Richard Vosser JPMorgan Chase;Co;Analyst

&-

Welcome to the Molecular Partners presentation at the JPMorgan healthcare conference. I'm Richard Vosser, European pharma analyst at JPMorgan. It's my great pleasure to present and welcome Patrick Amstutz, the CEO of Molecular Partners to the presentation today. If you have a question after Patrick's presentation and please put your hand up and wait for a microphone and we'll take your questions.

Patrick, welcome to the conference.

Patrick Amstutz Molecular Partners AG;Co;Founder
CEO, Member of Management Board & Director

Good to see. Thanks, Richard, for that kind intro, we were just exchanging that this is our number nine presentation next year will be 10. So next year, we'll definitely have to do some special celebration here together. Warm welcome to everyone here in the room, but also those on the webcast and I want to thank my coworkers also sitting here and as they have given me a very nice challenge. Still last year, they have worked so

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot